223 related articles for article (PubMed ID: 27161161)
1. The importance of minipigs in dermal safety assessment: an overview.
Stricker-Krongrad A; Shoemake CR; Liu J; Brocksmith D; Bouchard G
Cutan Ocul Toxicol; 2017 Jun; 36(2):105-113. PubMed ID: 27161161
[TBL] [Abstract][Full Text] [Related]
2. Miniature Swine Breeds in Toxicology and Drug Safety Assessments: What to Expect during Clinical and Pathology Evaluations.
Stricker-Krongrad A; Shoemake CR; Pereira ME; Gad SC; Brocksmith D; Bouchard GF
Toxicol Pathol; 2016 Apr; 44(3):421-7. PubMed ID: 26656239
[TBL] [Abstract][Full Text] [Related]
3. The Miniature Swine as a Model in Experimental and Translational Medicine.
Stricker-Krongrad A; Shoemake CR; Bouchard GF
Toxicol Pathol; 2016 Jun; 44(4):612-23. PubMed ID: 27073085
[TBL] [Abstract][Full Text] [Related]
4. Specificities of the Skin Morphology in Juvenile Minipigs.
Gauthier BE; Penard L; Bordier NF; Briffaux JJ; Ruty BM
Toxicol Pathol; 2018 Oct; 46(7):821-834. PubMed ID: 30348062
[TBL] [Abstract][Full Text] [Related]
5. The minipig in dermatotoxicology: methods and challenges.
Mahl JA; Vogel BE; Court M; Kolopp M; Roman D; Nogués V
Exp Toxicol Pathol; 2006 Jul; 57(5-6):341-5. PubMed ID: 16713702
[TBL] [Abstract][Full Text] [Related]
6. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
[TBL] [Abstract][Full Text] [Related]
7. The minipig as nonrodent species in toxicology--where are we now?
Ganderup NC; Harvey W; Mortensen JT; Harrouk W
Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
[TBL] [Abstract][Full Text] [Related]
8. The minipig in toxicology.
Svendsen O
Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
[TBL] [Abstract][Full Text] [Related]
9. Swine as models in biomedical research and toxicology testing.
Swindle MM; Makin A; Herron AJ; Clubb FJ; Frazier KS
Vet Pathol; 2012 Mar; 49(2):344-56. PubMed ID: 21441112
[TBL] [Abstract][Full Text] [Related]
10. Dermatotoxicology: Safety Evaluation of Topical Products in Minipigs: Study Designs and Practical Considerations.
Willard-Mack C; Ramani T; Auletta C
Toxicol Pathol; 2016 Apr; 44(3):382-90. PubMed ID: 26839328
[TBL] [Abstract][Full Text] [Related]
11. Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.
Yamamoto S; Karashima M; Sano N; Fukushi C; Tohyama K; Arai Y; Hirabayashi H; Amano N
Pharm Res; 2017 Nov; 34(11):2415-2424. PubMed ID: 28828717
[TBL] [Abstract][Full Text] [Related]
12. Minipigs in Translational Immunosafety Sciences: A Perspective.
Rubic-Schneider T; Christen B; Brees D; Kammüller M
Toxicol Pathol; 2016 Apr; 44(3):315-24. PubMed ID: 26839327
[TBL] [Abstract][Full Text] [Related]
13. The utility of the minipig as an animal model in regulatory toxicology.
Bode G; Clausing P; Gervais F; Loegsted J; Luft J; Nogues V; Sims J;
J Pharmacol Toxicol Methods; 2010; 62(3):196-220. PubMed ID: 20685310
[TBL] [Abstract][Full Text] [Related]
14. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Minipigs in the Development of Anticancer Therapeutics: Species Comparison and Examples of Special Applications.
Mahl A; Dincer Z; Heining P
Toxicol Pathol; 2016 Apr; 44(3):391-7. PubMed ID: 26698323
[TBL] [Abstract][Full Text] [Related]
16. Göttingen Minipigs in Ocular Research.
Shrader SM; Greentree WF
Toxicol Pathol; 2018 Jun; 46(4):403-407. PubMed ID: 29683084
[TBL] [Abstract][Full Text] [Related]
17. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.
van der Laan JW; Brightwell J; McAnulty P; Ratky J; Stark C;
J Pharmacol Toxicol Methods; 2010; 62(3):184-95. PubMed ID: 20601024
[TBL] [Abstract][Full Text] [Related]
18. New challenges and opportunities in nonclinical safety testing of biologics.
Baumann A; Flagella K; Forster R; de Haan L; Kronenberg S; Locher M; Richter WF; Theil FP; Todd M
Regul Toxicol Pharmacol; 2014 Jul; 69(2):226-33. PubMed ID: 24755365
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture.
Jewell C; Prusakiewicz JJ; Ackermann C; Payne NA; Fate G; Voorman R; Williams FM
Toxicol Appl Pharmacol; 2007 Dec; 225(2):221-8. PubMed ID: 17889094
[TBL] [Abstract][Full Text] [Related]
20. Juvenile toxicity: are we asking the right questions?
Downes N
Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
